Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul;26(1):49-52.

Progress and problems when considering gene therapy for GSD-II

Affiliations
Review

Progress and problems when considering gene therapy for GSD-II

A Kiang et al. Acta Myol. 2007 Jul.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kikuchi T, Yang HW, Pennybacker M, et al. Clinical and metabolic correcton of Pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest 1998;101:827-33. - PMC - PubMed
    1. Van den Hout H, Reuser AJ, Vulto AG, et al. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 2000;356:397-8. - PubMed
    1. Vanhove JLK, Yang HW, Wu JY, Brady RO, Chen YT. High-level production of recombinant human lysosomal acid alpha-glucosidase in chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci USA 1996;93:65-70. - PMC - PubMed
    1. Amalfitano A, Bengur AR, Morse RP, et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Gen Med 2001;3:132-8. - PubMed
    1. Amalfitano A. Utilization of adenovirus vectors for multiple gene transfer applications. Methods 2004;33:173-8. - PubMed

MeSH terms